Cargando…

Apolipoprotein A-I mimetic peptides (ApoAI MP) improve oxidative stress and inflammatory responses in Parkinson’s disease mice

Purpose: Parkinson’s disease (PD) is closely associated with oxidative stress and inflammatory situation. Apolipoprotein A-I mimetic peptides (ApoAI MP) have antioxidant and anti-inflammatory properties. We aimed to study the therapeutic effect of ApoAI MP on PD mice, and to explore the related mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Hongfang, Bai, Xue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437339/ https://www.ncbi.nlm.nih.gov/pubmed/36059954 http://dx.doi.org/10.3389/fphar.2022.966232

Ejemplares similares

ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
por: Edmunds, Shelley J., et al.
Publicado: (2019)

Haplotype analysis of ApoAI gene and sepsis-associated acute lung injury
por: Hao, Jian, et al.
Publicado: (2014)

Biosynthesis of lipoprotein: location of nascent apoAI and apoB in the rough endoplasmic reticulum of chicken hepatocytes
Publicado: (1992)

Coalition of DNA polymorphisms of ApoB and ApoAI genes is related with coronary artery disease in Kazaks
por: Huang, Gang, et al.
Publicado: (2012)

CD36 Is Significantly Correlated with Adipophilin in Human Carotid Lesions and Inversely Correlated with Plasma ApoAI
por: Collot-Teixeira, Sophie, et al.
Publicado: (2008)

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
por: Yao, Xianglan, et al.
Publicado: (2012)

Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins
por: Wang, Liyun, et al.
Publicado: (2014)

Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
por: Xu, Wenqi, et al.
Publicado: (2019)

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
por: Marinho, Aline T., et al.
Publicado: (2019)

The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography
por: Song, Yongyan, et al.
Publicado: (2015)

Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer
por: Peng, Meiyu, et al.
Publicado: (2020)

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2010)

Commentary: The apolipoprotein A-I mimetic peptide, D-4F, restrains neointimal formation through heme oxygenase-1 up-regulation
por: Li Volti, Giovanni, et al.
Publicado: (2017)

Combined LXR and RXR Agonist Therapy Increases ABCA1 Protein Expression and Enhances ApoAI-Mediated Cholesterol Efflux in Cultured Endothelial Cells
por: Huang, Kun, et al.
Publicado: (2021)

Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
por: Getz, Godfrey S, et al.
Publicado: (2011)

Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis
por: Sharifov, Oleg F., et al.
Publicado: (2013)

Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis
por: Mendez-Fernandez, Yanice, et al.
Publicado: (2010)

Apolipoprotein A-I and Cancer
por: Zamanian-Daryoush, Maryam, et al.
Publicado: (2015)

Comparison of Apolipoprotein Concentrations and Values of APOB:APOAI with Traditional Lipid Measures in Women Diagnosed with Acute Cornonary Syndromes – A Preliminary Report
por: Krintus, Magdalena, et al.
Publicado: (2011)

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
por: Wolska, Anna, et al.
Publicado: (2021)

Collagen Mimetic Peptides Promote Corneal Epithelial Cell Regeneration
por: Baratta, Robert O., et al.
Publicado: (2021)

The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
por: Di Bartolo, Belinda A, et al.
Publicado: (2011)

Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression
por: Peng, Meiyu, et al.
Publicado: (2017)

Apolipoprotein E mimetic peptide protects against diffuse brain injury
por: Zhao, Yaning, et al.
Publicado: (2014)

Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia
por: Wolkowicz, Paul, et al.
Publicado: (2021)

Importance of Apolipoprotein A-I in Multiple Sclerosis
por: Gardner, Lidia A., et al.
Publicado: (2015)

Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux
por: Islam, Rafique M., et al.
Publicado: (2018)

An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration
por: Chen, Xun, et al.
Publicado: (2009)

Restoring the Extracellular Matrix: A Neuroprotective Role for Collagen Mimetic Peptides in Experimental Glaucoma
por: McGrady, Nolan R., et al.
Publicado: (2021)

The Apolipoprotein-AI Mimetic Peptide L4F at a Modest Dose Does Not Attenuate Weight Gain, Inflammation, or Atherosclerosis in LDLR-Null Mice
por: Averill, Michelle M., et al.
Publicado: (2014)

Apolipoprotein E mimetic peptide, CN‐105, improves outcomes in ischemic stroke
por: Tu, Tian Ming, et al.
Publicado: (2017)

Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
por: Georgila, Konstantina, et al.
Publicado: (2019)

ApoE mimetic peptide decreases Aβ production in vitro and in vivo
por: Minami, S Sakura, et al.
Publicado: (2010)

Mechanistic Insights into the Activation of Lecithin–Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids
por: Giorgi, Laura, et al.
Publicado: (2022)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
por: Rivas-Urbina, Andrea, et al.
Publicado: (2020)

Apolipoprotein E mimetic peptide COG1410 combats pandrug-resistant Acinetobacter baumannii
por: Wang, Bo, et al.
Publicado: (2022)

Development of an apolipoprotein E mimetic peptide–lipid conjugate for efficient brain delivery of liposomes
por: Kato, Naoya, et al.
Publicado: (2023)

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation
por: Lu, Jing, et al.
Publicado: (2023)

Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice
por: McGrath, Kristine C., et al.
Publicado: (2020)

An Apolipoprotein A-I Mimetic Peptide Designed with a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice
por: Ditiatkovski, Michael, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mlrj5j9dfggqv3jife008d4tqh